Immunotherapy drugs fight cancer by helping the immune system recognise and attack cancer cells. These drugs have revolutionised cancer treatment over the last decade, improving survival for many people with different types of cancer. However, researchers are still unsure of the best way to give immunotherapy, which can come with unpredictable side effects. 

In this episode, Clinical Fellow Sophie Merrick discusses how the REFINE trial hopes to address this problem, by testing if giving immunotherapy less frequently can still treat the cancer effectively, whilst improving the quality of life for patients, reducing side effects and costs. 

For more information and to access the transcript: www.mrcctu.ucl.ac.uk/news/news-stories/2023/july/new-podcast-episode-the-refine-trial-how-can-we-improve-the-way-we-give-cancer-immunotherapy/

Date of episode recording: 2023-04-19
Duration: 00:16:57
Language of episode: English
Presenter: Berta Terre-Torras
Guests: Sophie Merrick
Producer: Berta Terre-Torras